<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has filed a disclosure with BSE on April 15, 2025, confirming that it does not qualify as a 'Large Corporate' under SEBI's circular dated November 26, 2018, which deals with fund raising through debt securities by large entities. As of March 31, 2025, the company falls below the threshold criteria defined in that framework. The filing was signed by Director Ashok Somani (DIN: 03063364) and submitted to BSE under Script ID 506365. This is a routine annual compliance disclosure rather than any fund-raising action.
No material impact on shareholders or stock price. This is a routine compliance filing confirming the company is exempt from mandatory debt-security issuance requirements under the SEBI Large Corporate framework, simply because it does not meet the size threshold.